The Role Of Iron-Overloaded Macrophages In Mesenchymal Stem Cell Senescence And Anemia In Myelodysplastic Syndromes: Protocol For An In Vitro Study
Myelodysplastic syndromes (MDS) are a group of blood disorders where the bone marrow doesn’t produce enough healthy blood cells, often leading to severe anemia. While we know that anemia is a major issue for these patients, the exact reasons behind it are still being uncovered. Preliminary evidence suggests that in the bone marrow of individuals with MDS, there’s an increase in certain immune cells called macrophages, which are also overloaded with iron. Simultaneously, the supportive stem cells in the bone marrow, known as mesenchymal stem cells, show signs of premature aging and produce higher levels of an inflammatory signal called interleukin-6 (IL-6). This research aims to investigate a fascinating connection: could these iron-overloaded macrophages be directly causing the supportive stem cells to age faster and release more IL-6? The study will delve into a specific cellular defense mechanism, the Keap1-Nrf2-ARE pathway, to see if it plays a crucial role in this process. If this hypothesis holds true, it would mean that the iron accumulation in macrophages disrupts the normal function of the bone marrow’s supportive environment, ultimately hindering the production of healthy blood cells and worsening anemia. The insights gained from this work are expected to shed light on a new molecular pathway that contributes to anemia in MDS. More importantly, identifying this pathway could open doors for developing new treatments that specifically target iron overload or this cellular defense mechanism to improve the lives of patients suffering from these challenging blood disorders.
Source: link to paper